Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Women's Health Rheumatology Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial ● Currently Recruiting NCT07054073

HCMR Re-Imaging Study

HCMR Re-Imaging Study — Recruiting • Cardiology / Cardiovascular • NCT07054073.

📅 16 Oct 2026 ⏱ 2 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
NCT ID
NCT07054073
Sponsor
Christopher Kramer
Start
2026-07-27
ClinicaliQ Trial Snapshot
  • HCMR Re-Imaging Study — Recruiting • Cardiology / Cardiovascular • NCT07054073.
  • Sponsor: Christopher Kramer.

Verify eligibility, endpoints and current status on the original source registry before acting on this summary.

Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

This study aims to learn what might predict heart problems (like sudden death from a fast heart rhythm or heart failure) in people with a genetic condition called hypertrophic cardiomyopathy (HCM). HCM causes the heart muscle to become thick, which can make the heart stiff and harder to work properly. It can also affect the heart's electrical system. This study is looking to enroll patients that were previously part of a research project called "HCMR - Novel Predictors of Outcome in Hypertrophic Cardiomyopathy." The results of that study are still…

Eligibility Snapshot
  • : Patients in the original HCMR cohort with: 1. Obstructive HCM * Males and females between 18 and 65 years of age * BMI < 35 kg/m2 * LVOT-G at entry as follows: Resting gradient ≥50 mmHg OR Resting gradient ≥30 mmHg and

Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Clinical Brief
3D heart to let surgeons practise baby’s vital heart operation
Cardiology / Cardiovascular · BBC Health · 07 Apr 2026
3D heart models enable surgeons to practise complex congenital heart operations preoperatively, potentially improving surgical outcomes in neonatal cases Personalised anatomical models…
View brief →
Guideline
2023 ESC Guidelines on the Management of Endocarditis
Cardiology / Cardiovascular · 30 Mar 2026
Covers diagnostic criteria for infective endocarditis (Duke criteria) and appropriate imaging modalities • Provides antimicrobial treatment recommendations based on causative organisms and…
View guideline →
Clinical Brief
Inside Health
Cardiology / Cardiovascular · BBC Health · 13 Oct 2026
Key Takeaways for Clinical Practice Stroke incidence is rising disproportionately in Black communities – clinicians should be alert to potential disparities in…
View brief →
Clinical Brief
‘I was dead for 10 minutes, but lived to tell the tale’
Cardiology / Cardiovascular · BBC Health · 13 Oct 2026
Cardiac arrest survival is possible with rapid intervention: A patient in Spain survived 10 minutes of cardiac arrest, demonstrating the critical importance…
View brief →
Clinical Brief
Dad thankful charity scan revealed ‘silent’ heart attack
Cardiology / Cardiovascular · BBC Health · 10 Oct 2026
Asymptomatic coronary artery disease can be clinically significant—charity screening identified a blocked artery in a patient without symptoms, prompting necessary intervention Opportunistic…
View brief →
Clinical Brief
The children dying in India’s remote tribal heartland
Cardiology / Cardiovascular · BBC Health · 30 Sep 2026
Measles and malaria resurgence in vulnerable populations: At least 32 child deaths in Balaghat district highlight ongoing risks in remote tribal areas…
View brief →